Dose Response Curves for Microwave Ablation in the Cardioplegia-Arrested Porcine Heart
DOI:
https://doi.org/10.1532/hsf.428Abstract
Introduction: Microwave ablation has been used clinically for the surgical treatment of atrial fibrillation, particularly during valve procedures. However, dose- response curves have not been established for this surgical environment. The purpose of this study was to examine dosimetry curves for the Flex 4 and Flex 10 microwave devices in an acute cardioplegia-arrested porcine model.
Methods: Twelve domestic pigs (40-45 kg) were acutely subjected to Flex 4 (n = 6) and Flex 10 (n = 6) ablations. On a cardioplegically arrested heart maintained at 10-15oC, six endocardial atrial and seven epicardial ventricular lesions were created in each animal. Ablations were performed for 15 s, 30 s, 45 s, 60 s, 90 s, 120 s, and 150 s (65 W, 2.45 GHz). The tissue was stained with 2,3,5-triphenyl-tetrazolium chloride and lesions were sectioned at 5 mm intervals. Lesion depth and width were determined from digital photomicrographs of each lesion (resolution .03 mm).
Results: Average atrial thickness was 2.88 .4 mm (range 1.0 to 8.0 mm). 94% of ablated atrial sections created by the FLEX 4 (n = 16) and the FLEX 10 (n = 16) were transmural at 45 seconds. 100% of atrial sections were transmural at 90 seconds with the FLEX 10 (n = 14) and at 60 seconds with the Flex 4 device (n = 15). Lesion width and depth increased with duration of application.
Conclusion: Both devices were capable of producing transmural lesions on the cardioplegically arrested heart at 65 W. These curves will allow surgeons to ensure transmural ablation by tailoring energy delivery to the specific atrial geometry.
References
Adegboyega PA, Adesokan A, Haque A, Boor PJ. 1997. Sensitivity and specificity of triphenyl tetrazolium chloride in the gross diagnosis of acute myocardial infarcts. Arch Pathol Lab Med 121:1063-8.nCox JL, Ad N, Palazzo T, et al. 2000. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12:15-9.nCox JL, Sundt TM III. 1997. The surgical management of atrial fibrillation. Ann Rev Med 48:511-23.nDamiano RJ Jr. 2003. Alternative energy sources for atrial ablation: Judging the new technology. Ann Thorac Surg 75:329-30.nGillinov AM, Smedira NG, Cosgrove DM III. 2002. Microwave ablation of atrial fibrillation during mitral valve operations. Ann Thorac Surg 74:1259-61.nManasse E, Medici D, Ghiselli S, et al. 2003. Left main coronary arterial lesion after microwave epicardial ablation. Ann Thorac Surg 76:276-7.nMassen JG, Nijs JFMA, Smeets JLRM, et al. 2002. Beating-heart surgical treatment of atrial fibrillation with microwave ablation. Ann Thorac Surg 74:1307-11.nKnaut M, Spitzer SG, Karolyi L, et al. 1999. Intraoperative microwave ablation for curative treatment of atrial fibrillation in open heart surgery: the MICRO-STAF and MICRO-PASS pilot trial. Thorac Cardiovasc Surg 47(Suppl):379-84.nKnaut M, Tugtekin SM, Spitzer S, Gulielmos V. 2002. Combined atrial fibrillation and mitral valve surgery using microwave technology. Sem Thorac Cardiovasc Surg 14(3):226-31.nSaltman AE. 2003. A complete endoscopic approach to microwave ablation for atrial fibrillation. Heart Surg Forum 6(3):38-41.nVenturini A, Polesel E, Cutaia V, et al. 2003. Intraoperative microwave ablation in patients undergoing valvular surgery: Midterm results. Heart Surg Forum 6:409-11.nWilliams MR, Argenziano M, Oz MC. 2002(a). Microwave ablation for surgical treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 14(3):232-37.nWilliams MR, Knaut M, Berube D, Oz MC. 2002(b). Application of microwave energy in cardiac tissue ablation: from in vitro analyses to clinical use. Ann Thorac Surg 74:1500-5.n
